MedTrace Logo

Uses of Gamma Irradiated Amniotic Membrane as an Alternative Method in Psoriasis Treatment

NCT03440541 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2019-06-27

No results posted yet for this study

Summary

Using of human amniotic membrane extra-cellular matrix as a topical treatment for improving Psoriasis Area and Severity Index (PASI).

Conditions

Interventions

COMBINATION_PRODUCT

REGE pro

REGE pro is a patch of human amniotic membrane sterilized by gamma radiation

Sponsors & Collaborators

  • Egyptian Atomic Energy Authority

    lead OTHER_GOV

Principal Investigators

  • Nashwa K Radwan, PhD · NATIONAL CENTER FOR RADIATION RESEARCH AND TECHNOLOGY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-08-04
Primary Completion
2016-02-13
Completion
2016-04-08

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03440541 on ClinicalTrials.gov